Cilcare
Created in 2014
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
265 4,753Activities
Technologies
Entity types
Location
Rue du Professeur Joseph Anglada, 34090 Montpellier, France
Montpellier
France
Employees
Scale: 11-50
Estimated: 44
SIREN
803146125Engaged corporates
43
13 39Added in Motherbase
5 years, 7 months ago
biotech Value proposition
MAKING HEARING A PRIORITY
CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases.
CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus.
CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy.
CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring.
We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.
hearing disorders, tinnitus, hearing loss, pharmaceutical development, pharmacology, clinical development, preclinical development, GLP ototoxicology, hearing loss, tinnitus, auditory safety, ear disorders, AI, and precision medicineOriginal language
MAKING HEARING A PRIORITY
CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases.
CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus.
CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy.
CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring.
We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.
Accueil - Cilcare
https://www.cilcare.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Not capitalistic Not partnership Event 3 Jun 2021 17 May 2023 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Not capitalistic Partnership Event 22 Sep 2021 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 12 Apr 2022 19 Nov 2024 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 8 Jun 2016 12 Nov 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Nov 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 27 Aug 2024 | | |
 Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Other 7 Nov 2022 | | |
 BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Not capitalistic Not partnership Event 2 May 2018 21 Jan 2024 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Not capitalistic Not partnership Event 21 Jun 2022 26 Jul 2024 | | |
 Créalia Occitanie Civic and Social Organizations | Créalia Occitanie Civic and Social Organizations | Not capitalistic Not partnership Event 1 Jun 2021 16 Jul 2024 | | |